(Press-News.org) High-tech genomics and traditional Chinese medicine come together as researchers identify the genes responsible for the intense bitter taste of wild cucumbers. Taming this bitterness made cucumber, pumpkin and their relatives into popular foods, but the same compounds also have potential to treat cancer and diabetes.
"You don't eat wild cucumber, unless you want to use it as a purgative," said William Lucas, professor of plant biology at the University of California, Davis and coauthor on the paper to be published Nov. 28 in the journal Science.
That bitter flavor in wild cucurbits -- the family that includes cucumber, pumpkin, melon, watermelon and squash -- is due to compounds called cucurbitacins. The bitter taste protects wild plants against predators.
The fruit and leaves of wild cucurbits have been used in Indian and Chinese medicine for thousands of years, as emetics and purgatives and to treat liver disease. More recently, researchers have shown that cucurbitacins can kill or suppress growth of cancer cells.
Bitterness is known to be controlled by two genetic traits, "Bi" which confers bitterness on the whole plant and "Bt", which leads to bitter fruit. In the new work, Lucas, Sanwen Huang at the Chinese Academy of Agricultural Sciences and colleagues employed the latest in DNA sequencing technology to identify the exact changes in DNA associated with bitterness.
They also tasted a great many cucumbers. "Luckily this is an easy trait to test for," Lucas said. "You just chomp on a cucumber leaf of fruit and your tongue gives you the readout!"
They were able to identify nine genes involved in making cucurbitacin, and show that the trait can be traced to two transcription factors that switch on these nine genes, in either leaves or the fruit, to produce cucurbitacin.
The new research shows how domestication tweaked cucumber genetics to make the fruit more edible. Understanding that process might open up approaches to developing other food crops based on plants that are naturally either inedible or poor in nutrition, Lucas said.
It could also make it much easier to produce cucurbitacins in large enough quantities to use in clinical trials and potentially in medicine, Lucas said. For example the anti-malarial drug artemisinin, originally derived from traditional Chinese medicine, is now being produced either as a precursor molecule in yeast or through synthetic biology systems.
INFORMATION:
Other collaborators on the study included researchers at the Institute of Vegetables and Flowers, Beijing; Agricultural Genomics Institute, Shenzhen, China; Nanjing Agricultural University, Nanjing; Hunan Agricultural University, Changsha; Institute of Botany, Chinese Academy of Sciences, Beijing; Hunan Academy of Agricultural Sciences, Changsha; Wuhan University, Wuhan; Institute of Microbiology, Chinese Academy of Sciences, Beijing; Nihon University, Tokyo, Japan; and Wageningen University, Wageningen, The Netherlands.
Human-induced changes to Earth's carbon cycle - for example, rising atmospheric carbon dioxide and ocean acidification - have been observed for decades. However, a study published this week in Science showed human activities, in particular industrial and agricultural processes, have also had significant impacts on the upper ocean nitrogen cycle.
The rate of deposition of reactive nitrogen (i.e., nitrogen oxides from fossil fuel burning and ammonia compounds from fertilizer use) from the atmosphere to the open ocean has more than doubled globally over the last 100 years. ...
MEDFORD/SOMERVILLE, Mass.(November 27, 2014, 2 PM) -- New catalysts designed and investigated by Tufts University School of Engineering researchers and collaborators from other university and national laboratories have the potential to greatly reduce processing costs in future fuels, such as hydrogen. The catalysts are composed of a unique structure of single gold atoms bound by oxygen to several sodium or potassium atoms and supported on non-reactive silica materials. They demonstrate comparable activity and stability with catalysts comprising precious metal nanoparticles ...
People affected by a common inherited form of autism could be helped by a drug that is being tested as a treatment for cancer.
Researchers who have identified a chemical pathway that goes awry in the brains of Fragile X patients say the drug could reverse their behavioural symptoms.
The scientists have found that a known naturally occurring chemical called cercosporamide can block the pathway and improve sociability in mice with the condition.
The team at the University of Edinburgh and McGill University in Canada identified a key molecule - eIF4E - that drives excess ...
Led by a University of Oklahoma professor, an international team of researchers has discovered the first evidence of milk consumption in the ancient dental calculus--a mineralized dental plaque--of humans in Europe and western Asia. The team found direct evidence of milk consumption preserved in human dental plaque from the Bronze Age to the present day.
"The study has far-reaching implications for understanding the relationship between human diet and evolution," said Christina Warinner, professor in the OU Department of Anthropology. "Dairy products are a very recent, ...
Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims--and are now searching for drugs to block it.
Strokes happen when the blood supply to part of the brain is cut off but much of the harm to survivors' memory and other cognitive function is often actually caused by "oxidative stress" in the hours and days after the blood supply resumes.
A team from the University of Leeds and Zhejiang University in China studied this second phase of damage in laboratory mice and found a mechanism in neurons that, if removed, reduced the ...
A large-scale study led by the University of Exeter has found that boys are more likely to be stillborn than girls. Published in the journal BMC Medicine, the study reviewed more than 30 million births globally, and found that the risk of stillbirth is about ten percent higher in boys. This equates to a loss of around 100 000 additional male babies per year.
The results could help to explain why some pregnancies go wrong. Around a quarter of stillbirths have no known cause. Of the remainder, many are linked to placental abnormalities but it is often unclear why the abnormalities ...
Drinking 3-5 cups of coffee per day may help to protect against Alzheimer's Disease, according to research highlighted in an Alzheimer Europe session report published by the Institute for Scientific Information on Coffee (ISIC), a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health.
The number of people in Europe aged over 65 is predicted to rise from 15.4% of the population to 22.4% by 20251 and, with an aging population, neurodegenerative diseases such as Alzheimer's Disease are of increasing concern. Alzheimer's Disease ...
Using world-leading research methods, the team of Dr David Wright and Prof Paul Holmes, working with Dr Jacqueline Williams from the Victoria University in Melbourne, studied activity in an area of the brain responsible for controlling movements when healthy participants observed a video showing simple hand movements and simultaneously imagined that they were performing the observed movement.
Using transcranial magnetic stimulation - a technique where a coil placed over the scalp delivers a stimulation to the brain, activates neurons in the underlying area, and causes ...
TORONTO, Nov. 26, 2014 - Ontario students between Grades 9 and 12 who said they had a traumatic brain injury in their lifetime, also reported drug use rates two to four times higher than peers with no history of TBI, according to research published today in The Journal of Head Trauma Rehabilitation.
"Overall, a teen with a history of TBI is at least twice as likely as a classmate who hasn't suffered a brain injury to drink alcohol, use cannabis or abuse other drugs," said Dr. Michael Cusimano, co-principal investigator of the study and a neurosurgeon at St. Michael's ...
This news release is available in French.
The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret. The study confirms that the external artificial pancreas improves glucose control and reduces the risk of hypoglycemia compared to conventional diabetes treatment. The results, published today in the scientific journal The Lancet Diabetes & Endocrinology, could have a significant impact on the ...
